Zai Lab Ltd (ZLAB)
147.52
+0.13 +0.09%
NASDAQ
Feb 26, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 22.63M |
| Revenue (Annual YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -3.11 |
| EPS Diluted (Annual YoY Growth) | Upgrade |
| Net Income (TTM) | -211.89M |
| Profitability | |
| Gross Profit Margin | Upgrade |
| Profit Margin | Upgrade |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 12.99B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 439.20 |
| PE Ratio | -- |
| Price to Book Value | 27.90 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Annual) | Upgrade |
| Free Cash Flow | -181.79M |
| Return on Equity | Upgrade |
View All ZLAB News
News
-
WireHeadlineTime (ET)
-
Yahoo02/27 09:23
-
Globe Newswire02/18 07:30
-
SA Breaking News02/08 15:47
-
MT Newswires02/03 10:54
-
MT Newswires02/03 10:39
-
Globe Newswire01/28 07:30
-
MT Newswires01/21 10:54
-
MT Newswires01/11 05:31
-
Globe Newswire01/11 04:30
-
MT Newswires01/07 12:58
-
MT Newswires01/06 16:49
-
SA Breaking News01/04 17:49
-
MT Newswires01/04 10:46
-
Globe Newswire12/30 07:30
-
Yahoo12/30 06:05
-
Yahoo12/29 08:09
-
MT Newswires12/29 07:07
-
Yahoo12/28 19:00
-
Globe Newswire12/28 19:00
-
SA Breaking News12/28 08:07
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 03/01/2021 | Earnings | Zai Lab Ltd Third Quarter Earnings Result for 2020 |
| 03/01/2021 08:00 EST | Misc | Zai Lab Ltd Third Quarter Earnings Conference Call for 2020 |
| 08/13/2020 08:00 EDT | Misc | Zai Lab Ltd Second Quarter Earnings Conference Call for 2020 |
| 08/13/2020 | Earnings | Zai Lab Ltd Second Quarter Earnings Result for 2020 |
| 04/29/2020 | Misc | Zai Lab Ltd Annual Report for 2019 |
| 03/19/2020 08:30 EDT | Misc | Zai Lab Ltd Fourth Quarter Earnings Conference Call for 2019 |
| 03/19/2020 | Earnings | Zai Lab Ltd Fourth Quarter Earnings for 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.zailaboratory.com
- Investor Relations URL: N/A
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Large Cap/Growth
- Next Earnings Release: Mar. 01, 2021
- Last Earnings Release: Aug. 13, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101. The company operates through the segment being Developing and commercializing proprietary therapeutics.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 147.52 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| CHB | Global X China Biotech Innovation ETF | 7.39% |
| CHIH | Global X MSCI China Health Care ETF | 5.44% |
| GERM | ETFMG Treatments Testing and Adv ETF | 4.66% |
| KURE | KraneShares MSCI All China Hlth Care ETF | 2.83% |
| BEXUX | Baron Emerging Markets R6 | 2.64% |
| PGJ | Invesco Golden Dragon China ETF | 2.50% |
| BGLUX | Baron Global Advantage R6 | 1.87% |
| HGHVX | Hartford Healthcare R6 | 1.68% |
| FKBSX | Federated Hermes Kaufmann Small Cap B | 1.50% |
| KAUBX | Federated Hermes Kaufmann B | 1.42% |
| CNWFX | American Funds New World 529F | 1.24% |
| MEE.TO | Mackenzie Maximum Divers Emerg Mkts ETF | 0.63% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ZLAB Tweets Stocktwits
Advertisement
